Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by Region
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. The high incidence rate of cardiovascular diseases
4.2.2. Improved spending on healthcare in emerging markets
4.2.3. Technological Advancements in Remote Monitoring Technologies
4.3. Restraints:
4.3.1. Complex Reimbursement Policies
4.4. Opportunity
4.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Value Chain Analysis
5.4. PEST Analysis
5.5. Pricing Analysis
5.6. Regulatory Analysis
5.7. Reimbursement Analysis
5.8. Unmet Needs
5.9. Patent Trends
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
7.3. Market Attractiveness Index, By Product Segment
7.3.1. Event Monitoring and MCT (Mobile Cardiac Telemetry)
7.3.1.1. Introduction
7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.3.2. Others
8. By Application
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.3. Market Attractiveness Index, By Application Segment
8.3.1. Arrhythmias*
8.3.1.1. Introduction
8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.3.2. Myocardial Ischemia and Infarction
8.3.3. Pacemaker Monitoring
8.3.4. Others
9. By Region
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
9.3. Market Attractiveness Index, By Region
9.4. North America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. The U.S.
9.4.5.2. Canada
9.4.5.3. Mexico
9.5. Europe
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. Germany
9.5.5.2. The U.K.
9.5.5.3. France
9.5.5.4. Italy
9.5.5.5. Spain
9.5.5.6. Rest of Europe
9.6. South America
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.6.5.1. Brazil
9.6.5.2. Argentina
9.6.5.3. Rest of South America
9.7. Asia Pacific
9.7.1. Introduction
9.7.2. Key Region-Specific Dynamics
9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.7.5.1. China
9.7.5.2. India
9.7.5.3. Japan
9.7.5.4. Australia
9.7.5.5. Rest of Asia Pacific
9.8. The Middle East and Africa
9.8.1. Introduction
9.8.2. Key Region-Specific Dynamics
9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Aerotel Medical Systems Ltd.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. BioTelemetry Inc.
11.3. GE Healthcare
11.4. Medtronic Plc
11.5. iRhythm Technologies Inc.
11.6. Nihon Kohden Corporation
11.7. Philips Healthcare
11.8. Medicalgorithmics SA
11.9. Preventice Solutions Inc.
11.10. Hill-Rom Services Inc. (Welch Allyn)
11.11. Other Companies
12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us